1-1 of 1
Andrew Grigg, MB BS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Two Year Data from a Prospective Safety Study Analyzing the Consequences of Imatinib Mesylate Inhibition of Sensitive Kinases Other Than bcr-abl in Patients with Previously Untreated Chronic Phase CML.

John Francis Seymour, MBBS, PhD, Andrew Grigg, MB BS, John Reynolds, Ph D, Anthony P. Schwarer, MB BS PhD, Richard Hermann, MB BS, Kerry McDonald Taylor, MB BS, Kenneth Francis Bradstock, MB BS PhD, Anthony K. Mills, MB BS, Rachel Koelmeyer, BSc, Kevin Lynch, Timothy Hughes, MBBS MD
Journal: Blood
Blood (2006) 108 (11): 2147.
https://doi.org/10.1182/blood.V108.11.2147.2147
Published: 2006